Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Key figures
- Market capClose on Nov 9, 2026
- $686.4M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $135.1K in total
- 4
- 13F holdersQ2 2026, +11 vs. previous quarter
- 239
- 13F valueReported value at the end of Q2 2026
- $1.06B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $42.7M
- −60.5% year over year
- Net income, FY2025
- -$204.4M
- No comparable prior period
- Free cash flow, FY2025
- -$188.2M
- No comparable prior period
- Revenue, Q3 FY2026
- $13.2M
- No comparable prior period
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $204.4M (478.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 21.2M
- Shares sold short
- Change
- +2.61M
- +14.1% vs. previous
- Days to cover
- 6.53
- At average daily volume
Superinvestors holding WVE, Q2 2026
Go to the superinvestors tab2 superinvestors report holding Wave Life Sciences, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Maverick Capital
Lee Ainslie
0.5%
Wave Life Sciences, Inc.'s share of the portfolio
- Shares
- 10,278,115
- Value
- $59.7M
Duquesne Family Office
Stanley Druckenmiller
<0.1%
Wave Life Sciences, Inc.'s share of the portfolio
- Shares
- 173,000
- Value
- $1.00M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Wave Life Sciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Wagner Heidi LDirector | SSale | −7.00K | $6.01 | −$42.1K | −13.5%44.9K after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 12 | 1 day | Rawcliffe AdrianDirector | SSale | −12.7K | $5.29 | −$67.2K | −100.0%0 after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Takanashi KenDirector | SSale | −3.86K | $6.01 | −$23.2K | −16.1%20.1K after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Tan Aik NaDirector | SSale | −432 | $6.01 | −$2.60K | −1.7%25.0K after | 10b5-1 |
| Mar 30, 2026 (view filing)8:30 PM ET | Mar 26-30 | 4 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | PPurchase | +8.77M | $6.23 | +$54.6M | +48.2%27.0M after | 4 lots |
| Feb 27, 2026 (view filing) | Feb 26 | 1 day | Francis ChrisSee Remarks | SSale | −33.2K | $15.05 | −$499.5K | −34.9%61.9K after | 2 lots10b5-1 |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Moran KyleChief Financial Officer | SSale | −3.59K | $13.45 | −$48.3K | −2.6%134.4K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Bolno PaulPresident and CEO | SSale | −10.5K | $13.45 | −$141.0K | −3.7%275.5K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Francis ChrisSee Remarks | SSale | −1.88K | $13.45 | −$25.3K | −3.0%61.9K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Vargeese ChandraSee Remarks | SSale | −3.23K | $13.45 | −$43.4K | −0.8%408.2K after |
Top 10 13F holders, Q2 2026
See all 239 holdersThe largest institutional positions in Wave Life Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 26,975,505 | $156.7M | 1.36% | 00.0% | Unchanged |
| BlackRock, Inc. | 19,202,461 | $111.6M | 0.00% | +5,085,049+36.0% | Added |
| GSK plc | 18,245,691 | $106.0M | 17.60% | 00.0% | Unchanged |
| Maverick Capital LtdSuperinvestorMaverick Capital | 10,278,115 | $59.7M | 0.54% | +116,716+1.1% | Added |
| Driehaus Capital Management LLC | 5,443,143 | $31.6M | 0.18% | +12,122+0.2% | Added |
| Primecap Management Co | 5,354,622 | $31.1M | 0.02% | +521,670+10.8% | Added |
| 683 Capital Management, LLC | 4,950,000 | $28.8M | 2.64% | +50,000+1.0% | Added |
| FMR LLC | 4,922,477 | $28.6M | 0.00% | −270,284−5.2% | Reduced |
| State Street Corp | 4,839,317 | $28.1M | 0.00% | +1,165,284+31.7% | Added |
| Readystate Asset Management LP | 4,727,139 | $27.5M | 1.12% | +4,727,139 | New |
Holders of 5% or more of WVE
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Wave Life Sciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D/A | 16.80%34.3M shares | −0.30 ppfrom 17.10% | Aug 18, 20219 filings | Aug 11, 2026 | SEC |
| BlackRock, Inc. | 13G | 6.80%13.4M shares | New | Oct 27, 20261 filing | Oct 27, 2026 | SEC |
| Maverick Capital LtdSuperinvestorMaverick Capital | 13G/A | 5.40%8.26M shares | – | Feb 14, 20224 filings | Feb 14, 2025 | SEC |